Cheapest isn't a good indication if it meets the ASX200 as companies like Syrah Resources and Estia Health will be booted out of the ASX200 eroding a lot of shareholder equity. Has to be at least within the 200 marketcap valuations deemed to be ASX200 worthy leading up to the rebalance and shown to have adequate liquidity properties. Fortunately Nearmap does indeed satisfy both.
Cheapest isn't a good indication if it meets the ASX200 as...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
